RxDoctor Payments Data

Brittany Martin

Primary Care · Sipsey, ALNPI 1306335666

Payments from drug & device makers

$1,090in general payments, 2019–2025

Across 81 payments — averaging $13.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$357
  • AstraZeneca$158
  • Novo Nordisk$123
  • GSK$83
  • Otsuka America Pharmaceutical, Inc.$42
  • Bayer$41
  • plus $286 from 12 others

What the payments were for

  • Food & beverage$1,090100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,090 in reported general payments places this provider in the 55th percentile of 159 primary care providers in Alabama.

See all primary care providers in Alabama

Medicare billing

Part B allowed, 2024
$13,224
Medicare patients
81
Services billed
599

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide19$26,755
EliquisApixaban23$19,712
FarxigaDapagliflozin Propanediol23$19,004
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$16,538
XareltoRivaroxaban24$16,339
OzempicSemaglutide17$16,273
MounjaroTirzepatide12$14,255
MyrbetriqMirabegron13$5,321
Albuterol Sulfate HfaAlbuterol Sulfate59$1,538
Montelukast Sodium64$1,106
Omeprazole62$1,080
Atorvastatin Calcium84$1,069
Fluticasone Propionate37$964
Cefdinir52$881
Amlodipine Besylate86$664

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$39$41,01131 claims
AstraZenecaFarxiga$158$19,00423 claims
GSKTrelegy Ellipta$83$16,53816 claims
Johnson & JohnsonXarelto$34$16,33924 claims
Novo NordiskOzempic$123$16,27317 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 159 primary care providers in Alabama.

Other primary care in Sipsey

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →